Skip to main content
News Icon

News categories: Publication

The helicase DHX36 resolves G-quadruplex structures and supports stress response

The helicase DHX36 resolves G-quadruplex structures and supports stress response

DNA and RNA G-quadruplex structures are thermodynamically very stable arrangements of four nucleic acid strands, in which the guanines interact via Hoogsteen base pairing. It has been shown that the formation or resolution of RNA G‑quadruplex structures has severe impacts on diverse cellular processes such as transcription or translation. Interestingly, the formation of G-quadruplex structures in untranslated regions of mRNAs can render these mRNAs translationally inactive. The Paeschke lab characterized the RNA targets of DHX36, a 3′−5′ DEAH-box helicase, and discovered that it performs an important function in resolving G-quadruplex structures in the 5´ and 3' untranslated regions of mRNAs. The deletion of DHX36 resulted in an increased formation of stress granules and the phosphorylation of protein kinase R (PKR), caused by the accumulation of G-quadruplex structures in the cytoplasm. PKR is an important factor for the innate immune system and the integrated stress response. PKR is activated upon phosphorylation, which leads to the shutdown of global protein synthesis. In summary, the Paeschke lab could demonstrate that G-quadruplex structures within mRNAs and the cellular stress response are connected and that this connection is established via DHX36 and PKR.


Publication

https://www.immunosensation.de/research/publications/pubmed/dhx36-prevents-the-accumulation-of-translationally-inactive-mrnas-with-g4-structures-in-untranslated.html


Contact

Prof. Katrin Paeschke

Medical Clinic III

Related news

News Icon

News categories: Publication

Twin Lancet Publications Highlight Promising New Approach for Lupus Treatment

A team of international researchers, including ImmunoSensation³ member Prof. Jörg Wenzel, reports promising phase 2 results for enpatoran, a first-in-class oral TLR7/8 inhibitor, in patients with cutaneous and systemic lupus erythematosus (CLE/SLE). In the WILLOW trial, enpatoran significantly improved skin disease activity in a dose-dependent manner and showed favourable safety outcomes. In systemic SLE, treatment also reduced global disease activity and rapidly suppressed the type I interferon gene signature. The twin studies were published in The Lancet and The Lancet Rheumatology.
View entry
Wissenschaftler

News categories: Publication

Driver of inflammation after mild head injury

Mild traumatic brain injuries can lead to persistent memory problems and an increased risk of dementia. Yet, effective therapies to counteract these long-term consequences are still lacking. Dr. Dr. Sergio Castro-Gomez, Early Career Research Group Leader at the Institute of Physiology II of the University Hospital Bonn has discovered together with colleagues that the ASC protein. The research team hopes to identify new targets for future therapeutic strategies. The study, published in the Journal of Clinical Investigation, lays the foundation for upcoming clinical trials.
View entry
PM Immunity Nebeling

News categories: Publication

Study reveals dynamic interactions between brain tumors and immune cells

Glioblastoma, the most common and aggressive brain tumor in adults, is difficult to treat because this cancer can invade the surrounding brain tissue and spread far beyond the original tumor mass. Researchers from the DZNE, the University Hospital Bonn (UKB), and ImmunoSensation³ at the University of Bonn have observed this infiltration process in the living brain using high-tech microscopy. Their study is based on research in mice with a form of brain tumor that closely resembles human glioblastoma.
View entry

Back to the news overview